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a b s t r a c t
Objectives: The aim of this randomized controlled study was to cephalometrically assess
possible changes in craniofacial morphology associated with long-term use of an adjustable
oral-appliance compared with continuous positive airway pressure (CPAP) in patients with
the obstructive sleep apnea/hypopnea syndrome (OSAHS). In addition, we wanted to study
the relationship between these possible changes and the degree of mandibular protrusion
associated with oral-appliance therapy.
Methods: Fifty-one patients were randomized to oral-appliance therapy and 52 patients to
CPAP therapy. At baseline and after follow-up (2.3  0.2 years), a lateral cephalogram of all
patients was made in maximum intercuspation to determine relevant cephalometric
variables. Both baseline and follow-up cephalograms were traced digitally whereupon
cephalometric variables were compared. Changes in craniofacial morphology between
the oral-appliance- and CPAP group were evaluated with a linear regression analysis.
Results: Compared with CPAP, long-term use of an oral-appliance resulted in small but
significant (dental) changes. Overbite and overjet decreased, 1.0 (1.5) mm and 1.7
(1.6) mm, respectively. Furthermore we found a retroclination (2.0 (2.8)8) of the upper
incisors and a proclination (3.7 (5.4)8) of the lower incisors. Moreover, the lower- and total
anterior facial height increased significantly, 0.8 (1.5) mm and 0.9 (1.4) mm, respectively.
No changes in skeletal variables were found. Linear regression analysis revealed that the
decrease in overbite was associated with the mean mandibular protrusion during follow-up
(B = 0.029, SE = 0.014, p < 0.05).
Conclusions: Oral-appliance therapy should be considered as a life long treatment, and there
is a risk of craniofacial changes to occur. Therefore, patients treated with an oral-appliance,
need a thorough follow-up by a dentist or dental-specialist experienced in the field of dental
sleep medicine.
Crown Copyright # 2010 Published by Elsevier Ltd. All rights
reserved.
avai lable at www.sc iencedi rec t .com
journal homepage: www.intl.elsevierhealth.com/journals/jden1. Introduction
The obstructive sleep apnea/hypopnea syndrome (OSAHS) is a
sleep-related breathing disorder, characterized by disruptive§ Financial disclosure statement: The present paper was written in par
* Corresponding author. Tel.: +31 50 3613840; fax: +31 50 3611136.
E-mail address: m.h.j.doff@kchir.umcg.nl (M.H.J. Doff).
0300-5712/$ – see front matter. Crown Copyright # 2010 Published b
doi:10.1016/j.jdent.2010.08.018snoring and repetitive partial or complete obstructions of the
upper-airway (i.e. hypopneas and apneas, respectively).1 The
severity of the disorder is usually expressed by the apnea–
hypopnea index (AHI), i.e. the mean number of apneas andtial fulfilment of the requirements for a PhD degree.
y Elsevier Ltd. All rights reserved.
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(AHI 5–15), moderate (AHI 15–30), or severe (AHI >30).25 As a
result of the condition patients may suffer from excessive
sleepiness, an increased risk of accidents, and an impaired
quality of life. Furthermore, patients have an increased risk of
ischemic heart disease, congestive heart failure, and stroke.2,3
For OSAHS patients, continuous positive airway pressure
(CPAP) is generally considered the treatment of choice.4
However, because of the obtrusive character of the device,
patients may abandon therapy. An oral-appliance aims at
relieving upper airway obstructions during sleep by reposi-
tioning the mandible in a forward and downward position.5
Oral-appliance therapy has been demonstrated to be effective
especially in mild and moderate OSAHS cases.6,7 However, in
severe OSAHS cases, CPAP is still the treatment of first choice.
When commencing oral-appliance therapy, side effects are
commonly reported in the initial period of use. These usually
transient and mild side effects include tooth pain, occlusal
changes in the morning, dry mouth or excessive salivation,
gum irritation, temporomandibular joint pain, temporoman-
dibular joint sounds and myofascial pain.8–15 Some authors
report that some of these side effects can be more severe and
continuous.9,16–18
Craniofacial changes related to long-term oral-appliance
use have been studied with cephalometry.15,19–23 Reported
long-term changes (2–3 years) in craniofacial morphology
were generally related to the patient’s dentition. Most studies
found a significant decrease in overjet and over-
bite.8,13,15,21,23,24 Furthermore a retroclination of the maxillary
incisors, a proclination of the lower incisors8,13,15,23,24 and a
more downward19–21 and forward21 position of the mandible
have been reported. In the majority of these studies, however,
a control group was absent. In addition, in most studies only
patients with mild-to-moderate OSAHS or asymptomatic
snorers were included. Furthermore, all studies except for
one23 evaluated the effects of an oral-appliance that was non-
adjustable and fixed the mandible in a predefined position at
50–75% of the maximum mandibular protrusion. Therefore,
the relationship between the amount of mandibular protru-
sion during follow-up and the extent of craniofacial changes is
an aspect that needs further study.
The aim of the present study was to cephalometrically
assess possible changes in craniofacial morphology associated
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minSaO2, lowest oxyhemoglobin saturation during sleep, NS, not signific
a Plus–minus values are means  standard deviations.compared with a CPAP control group, in patients with mild to
severe OSAHS. Secondly, we studied the relationship between
the occurrence of these changes and the degree of mandibular
protrusion during oral-appliance therapy.
2. Materials and methods
2.1. Patient selection
The effectiveness of an oral-appliance compared with CPAP
therapy for OSAHS was evaluated in a separate randomized
controlled trial.7 All patients in that study were recruited
through the Department of Home Mechanical Ventilation of
the University Medical Center Groningen, The Netherlands.
Subjects over 20 years of age and diagnosed with OSAHS (AHI
>5) based on polysomnography25 were eligible, and if they
obeyed predefined medical, psychological, and dental inclu-
sion criteria, patients were randomized for either oral-
appliance- (n = 51) or CPAP therapy (n = 52) (Table 1).
For the present study, we assessed changes in the
craniofacial morphology as a result of long-term oral-appli-
ance therapy in OSAHS patients. After 2 years, 37 patients
(including those who had switched) in the CPAP group and 31
patients (including those who had switched) in the oral-
appliance group completed the follow-up. Details of patient
selection criteria for our study are provided in Fig. 1. Patients
randomized for oral-appliance therapy who had switched to
CPAP therapy were excluded if they had been using the
appliance for more than 3 months. Patients who were
nonresponsive or nonadherent7 to treatment and patients who
underwent upper airway surgery during the follow-up period
were also excluded.
The present study was approved by the Groningen
University Medical Center’s Ethics Committee. Written in-
formed consent was obtained from each patient before
enrolment.
2.2. Study design
At baseline, patients had been subjected to a polysomno-
graphic evaluation, based on which they were classified as
having non-severe (AHI 5–30) or severe (AHI >30) OSAHS. In
all patients a digital lateral cephalogram was obtained atan oral-appliance or CPAP.
iancea (n = 51) CPAPa (n = 52)
3/8 49/3
9  10 49  10
2  6 33  6
9  31 40  28
4  4 45  4
8  9 78  10
re: n = 25 (49%) Non-severe: n = 25 (48%)
= 26 (51%) Severe: n = 27 (52%)
ant.
[(Fig._1)TD$FIG]
Fig. 1 – Flow diagram of the patient selection procedure. *Patients who discontinued treatment for any reason were
considered nonadherent to treatment. yTreatment was considered effective when the apnea–hypopnea index was <5 or
showed substantial reduction, defined as reduction in the index of at least 50% from the baseline value to a value of <20 in a
patient without symptoms while using therapy. Patients not meeting these criteria were considered nonresponsive.
j o u rn a l o f d e n t i s t r y 3 8 ( 2 0 1 0 ) 1 0 1 0 – 1 0 1 81012baseline to determine cephalometric variables related to the
craniofacial morphology.22,26–29 The oral-appliance used in
this study (Thornton Adjustable Positioner, Airway Manage-
ment Inc., Dallas, TX, USA) consisted of two separate parts,
fixing the patient’s mandible in a forward and downward
position. By turning a propulsion screw that was incorporated
anteriorly in the appliance, patients could gradually adjust the
mandibular advancement with 0.2 mm increments. The
maximal range of mandibular protrusion was first determined
with a George-GaugeTM (H-Orthodontics, Michigan City, IN,
USA). When initiating oral-appliance therapy, the mandible
was set at approximately 50% of the patient’s maximum
protrusion. After having accustomed to this protrusive
position during a 2-week period, patients were allowed to
adjust the oral-appliance during a 6-week period. When
OSAHS symptomatology (snoring, excessive daytime sleepi-
ness, apneas and/or hypopneas) appeared to persist, patients
were instructed to advance the mandible each night with 1–2
increments (i.e. 0.2–0.4 mm). Adjustment of the oral-appliance
was continued until symptoms had improved to the patient’s
satisfaction, or until further protrusion of the mandible
resulted in discomfort.
CPAP-adjustment was performed during an afternoon nap.
This technique, aimed at abolishing all signs of apneas,
hypopneas and snoring, has been shown to be an appropriate
procedure for the effective adjustment of CPAP.30
Following CPAP- and oral-appliance adjustment, an 8 week
follow-up period was arranged that allowed for habituation
and, if necessary, adjustment of CPAP or the oral-appliance.
After this period, a second polysomnographic study was
performed. If polysomnography indicated an apnea–hypop-
nea index5, CPAP or the oral-appliance was further adjusted.
A third polysomnographic study was performed 4 weeks after
that adjustment.
Treatment was considered effective when the apnea–
hypopnea index either was <5 or showed ‘‘substantialreduction,’’7 defined as reduction in the index of at least
50% from the baseline value to a value of <20 in a patient who
had no symptoms while using therapy. Patients, for whom
oral-appliance or CPAP therapy was effective, continued this
treatment. If either treatment was not effective at any time
during the follow-up period, patients were offered the
alternative (CPAP or oral-appliance, respectively) therapy,
which was thereupon titrated in the same way as with the
initial therapy.
After a 2-year follow-up period all patients were subjected
to a final polysomnographic evaluation and a second digital
lateral cephalogram. The mean mandibular protrusion during
the follow-up period (expressed as percentage of the maxi-
mum mandibular protrusion) was used for further analysis.
The vertical dimension of the oral-appliance was kept
constant during the entire follow-up period. Both mandibular
protrusion and mouth opening (including the vertical overbite)
were measured with a digital sliding calliper with 0.01 mm
accuracy. These measurements were carried out at baseline,
after 2 months, 1 year and 2 years of treatment. At these
intervals also other clinical measurements (weight, length,
neck circumference and intoxications) were carried out.
The primary outcome measure was the change in
craniofacial morphology, measured using cephalometric
variables, between baseline and the final follow-up visit.
Secondly the relationship between the mean mandibular
protrusion during the follow-up and the magnitude of changes
in the craniofacial morphology was studied.
2.3. Cephalometric analysis
All digital lateral cephalograms were recorded using a ProMax
Cephalostat (Planmeca, Helsinki, Finland). Themirror position31
was used in order to obtain a reproducible position of the head.
Patients were instructed to swallow and close their mouth
with the mandible in maximum intercuspation and the lips in
Table 2 – Cephalometric variables used in the study.
Variable Oral-appliancea n = 31 CPAPa n = 37 Significance of
the differenceb
(Cohen’s d) cBaseline Follow-up Difference Baseline Follow-up Difference
Base of the skull
Ba–S–N; the angle between the lines Ba–S and S–N (8) 48.8  5.4 48.6  5.3 0.22  0.7 47.7  6.7 47.4  6.7 0.30  1.1 NS
SN-length; distance between S and N (mm) 70.4  3.4 70.5  3.4 0.0  0.2 69.8  3.1 70.0  3.2 0.3  0.7 NS
Maxilla
SNA (8) 79.2  4.2 79.2  4.3 0.0  0,5 80.3  4.0 80.2  4.1 0.1  0.6 NS
Ui–MxP; angle between the upper incisor line and the
maxillary plane (8)
107.0  8.1 105.0  7.9 2.0  2.8y 114.1  8.3 113.9  8.3 0.2  3.1 p < 0.05 (0.6)
Maxillary length; distance between ans and pns (mm) 54.3  4.3 54.4  4.4 0.1  1.1 53.9 3.7 53.8 3.5 0.0  1.7 NS
Mandible
SNB (8) 75.2  3.9 74.8  4.2 0.4  0.9y 77.7  3.9 77.5  3.9 0.2  1.0 NS
Li–MnP; angle between the lower incisor line and the
mandibular plane (8)
102.2  7.4 105.9  8.2 3.7  5.4y 102.1  9.3 102.6  9.1 0.6  3.0 p < 0.05 (0.7)
MnP–SN; angle between the mandibular plane and SN-line (8) 34.3  7.1 34.7  6.8 0.4  1.1 31.7  6.3 31.9  6.1 0.2  1.4 NS
Ramus length; distance between Arm and Go (mm) 51.6  6.7 51.7  7.0 0.1  1.6 55.0  5.8 54.5  5.7 0.5  1.6 NS
Body length; distance between Go and Me (mm) 66.9  5.2 66.8  5.6 0.1  1.7 68.5  5.4 68.4  4.9 0.1  2.9 NS
Mandibular length; distance between Arm and Me (mm) 102.8  7.3 102.9  6.8 0.1  1.4 107.0  5.3 106.7  5.3 0.3  2.0 NS
Me-hor; shortest linear distance from Me to line SN-perp (mm) 31.6  9.6 30.9  9.7 0.7  1.6y 37.6  8.2 37.3  8.3 0.3  2.6 NS
Me-ver; shortest linear distance from Me to line SN (mm) 118.0  6.9 118.7  6.6 0.7  1.4y 118.7  6.3 118.7  6.3 0.0  1.5 NS
Arm-hor; shortest linear distance from Arm to line SN-perp
(mm)
16.9  3.0 17.0  3.3 0.1  1.4 15.6  3.1 15.8  3.4 0.2  1.2 NS
Arm-ver; shortest linear distance from Arm to line SN (mm) 27.8  3.3 28.0  3.2 0.2  0.8 26.1  3.4 26.4  3.6 0.3  1.2 NS
Intermaxillary relationships
ANB; angle between the lines NA and NB (8) 4.0  1.9 4.3  2.2 0.3  0.9y 2.5  3.1 2.6  2.8 0.1  0.9 NS
Ui–Li (interincisal angle); angle between the lines Ui and Li (8) 124.8  10.8 122.5  10.9 2.3  5.8y 120.4  13.4 119.7  13.0 0.6  0.7 NS
Overbite; linear dimension measured from the most mesial
point of the upper central incisor edge to the perpendicular
projection on the buccale surface of the lower central incisor
(mm)
2.4  2.4 1.4  2.4 1.0  1.5y 1.8  2.3 1.5  2.1 0.2  1.2 p < 0.05 (0.6)
Overjet; linear distance measured from the buccal surface of
the lower central incisor to the projected point of the incisal
edge of the upper central incisor (mm)
4.4  2.2 2.8  2.6 1.7  1.6y 3.3  2.9 3.5  2.8 0.2  1.3 p < 0.05 (1.3)
Facial height
Upper anterior facial height; distance between N and MxP
along line N–Me (mm)
53.4  3.7 53.5  3.5 0.0  0.5 52.5  3.0 52.6  2.8 0.1  0.6 NS
Lower anterior facial height; distance between MnP and MxP
along line N–Me (mm)
71.2  5.7 72.0  5.7 0.8  1.5y 70.7  5.0 70.8  4.9 0.1  0.6 p < 0.05 (0.6)
Total anterior facial height; distance between N and Me (mm) 124.6  7.6 125.4  7.4 0.9  1.4y 123.2  6.7 123.4  6.4 0.2  1.4 p < 0.05 (0.5)
Anterior facial height ratio; ratio between the upper anterior
facial height and the lower anterior facial height (percent)
75.5  7.1 74.6  6.8 0.8  1.9y 74.6  5.6 74.6  5.6 0.1 1.7 NS
Upper posterior facial height; distance between S and MxP
along line S–Go (mm)
42.9  4.4 43.2  4.5 0.3  1.0 42.3  3.6 42.4  3.7 0.1  0.8 NS
Lower posterior facial height; distance between Go and MxP
along line S–Go (mm)
39.2  7.0 39.3  7.3 0.1  2.2 40.9  5.6 40.7  5.7 0.2  1.4 NS



























































































































































































































































































































































































































































































































j o u rn a l o f d e n t i s t r y 3 8 ( 2 0 1 0 ) 1 0 1 0 – 1 0 1 81014a relaxed position. After a short period of relaxed tidal
breathing the cephalogram was taken at end-expiration. Early
morning visits were avoided because some patients were not
able to close in maximum intercuspation at that time but were
habituated to bite with the mandible in a more protrusive
position.
A predefined trace-protocol (Table 2 and Fig. 2) was used to
perform all tracings using Viewbox software1 (version 3.1.1.6,
Dhal Software, Kifissia, Greece). To minimize identification
error, one blinded observer (MD) performed all tracings.
Furthermore, for sagittal and vertical measurements, super-
imposition was performed on the anterior contour of the sella
turcica and sella-nasion (SN).32 In order to further reduce the
error of measurements, the coordinates of sella and nasion
were, after superimposition, transferred from the baseline to
the follow-up cephalogram in order to obtain exactly the same
coordinates on both cephalograms. All linear cephalometric
measurements were corrected for a radiographic enlargement
of 12%.
2.4. Statistical analysis
Statistical analyses were performed using the Statistical
Package for the Social Sciences (version 16.0, SPSS Inc.,
Chicago, IL, USA). All variables were normally distributed and
their means and standard deviations (s.d.) are reported. The
AHI of the oral-appliance and CPAP patients at baseline was
distributed normally after logarithmic transformation. To
compare outcomes between cephalometric variables at
baseline and follow-up, paired Student’s t-tests were per-
formed. Although proper randomisation is executed, a (small)
difference in the average values of a determinant for the two
treatment arms may occur. To correct for this regression-to-
the-mean fenomenon statistically in our analysis, the
baseline value was at all times included in the regression
model.
For continuous cephalometric measures, ‘between groups’
effect sizes are reported as Cohen’s d, the standardized mean
difference, based on mean group change scores divided by the
pooled standard deviation. The differences in craniofacial
morphology between the oral-appliance and CPAP group d
reflect the net side-effects associated with oral-appliance
therapy, a measure that controls for spontaneous changes in
the control group and pre-existing random group differences
at baseline. Cohen’s d effect sizes are interpreted as small
(0.20), medium (0.50), or large (>0.80)33.
For the oral-appliance group, linear regression analysis was
used to determine the relationship between the changes in
craniofacial morphology and the mean mandibular protrusion
during the follow-up period. A significance level of 0.05 was
predefined in all cases.
3. Results
For analysis, 31 and 37 patients were included in the oral-
appliance group and the CPAP group, respectively (Fig. 1). The
mean follow-up period was 2.3 (0.2) years in the oral-
appliance group (range 2.1–3.1 years) and 2.4 (0.3) years in the
CPAP group (range 2.1–3.2 years).
[(Fig._2)TD$FIG]
Fig. 2 – Cephalometric landmarks and reference lines
traced on lateral cephalograms. The following 18 reference
points were identified on lateral cephalograms: A (point A:
the deepest midline concavity on the anterior maxilla),
ans (anterior nasal spine: the tip of the median, sharp
bony process of the maxilla at the lower margin of the
anterior nasal opening), Ara (anterior articulare: the point
of intersection of the inferior cranial base surface and the
averaged anterior surfaces of the mandibular condyles),
Arm (articulare midpoint; the midpoint of the line between
Aa–Ar), Ar (articulare; the point of intersection of the
inferior cranial base surface and the averaged posterior
surfaces of the mandibular condyles), B (point B: the
deepest midline concavity on the mandibular symphysis),
Ba (Basion; the median point of the anterior margin of the
foramen magnum), Gn (gnathion: the most anterior-
inferior point on the contour on the bony chin symphysis.
Determined by bisecting the angle formed by the
mandibular plane and a line through pogonion and
nasion), Go (gonion: the constructed point of the
intersection of the ramus plane and the tangent to the
body of the mandible), Lia (lower incisor apex), Lie (lower
central incisor edge: the incisal tip of the mandibular
central incisor), Me (menton: the intersection of the bony
inferior symphysis with the inferior margin of the
mandibular body), N (nasion: the most anterior point on
the frontonasal suture), Pg (pogonion: the most anterior
point on the contour of the bony chin determined by a
tangent through nasion), pns (posterior nasal spine: the
intersection of a continuation of the anterior wall of the
pterygopalatine fossa and the floor of the nose, marking
the dorsal limit of the maxilla), S (sella; the midpoint of the
pituitary fossa), Uia (upper incisor apex), Uie (upper incisor
incisal edge: the incisal tip of themaxillary central incisor).
The following six reference lines were identified on lateral
cephalograms: Li (lower incisor line: the line through the
lower incisor apex and the lower incisor incisal edge), MnP
(mandibular plane according to Steiner: the line through
gonion and gnathion), MxP (maxillary plane: the line
j o u r n a l o f d e n t i s t r y 3 8 ( 2 0 1 0 ) 1 0 1 0 – 1 0 1 8 1015In the oral-appliance group, the mean mandibular protru-
sion during the follow-up period was 79 (20)% of the
maximal mandibular protrusion. The mean mouth opening
(including overbite) while wearing the oral-appliance was 13
(3) mm.
3.1. Cephalometric analysis
In the oral-appliance group, no significant changes were found
in the variables pertaining to the base of the skull. Concerning
maxillary measurements, the angle between the upper incisor
line and the maxillary plane (Ui–MxP) decreased 2.0 (2.8)
degrees as a result of long-term oral-appliance therapy
compared with CPAP therapy, indicating a retroclination of
the maxillary incisors (Table 2).
Mandibular measurements showed that the position of the
mandible in relation to the skull base, i.e. the SNB-angle, was
reduced 0.4 (0.9)8 and the angle between the lower incisor
line and the mandibular plane (Li–MnP) increased 3.7 (5.4)8,
indicating a proclination of the mandibular incisors. Further-
more, a downward and backward rotation of the mandible was
observed, as the shortest linear distance from menton to line
SN-perp (Me-hor) decreased 0.7 (1.6) mm and the shortest
linear distance between menton and line SN (Me-ver)
increased 0.7 (1.4) mm.
Regarding the intermaxillary relationships, the ANB-angle
increased 0.3 (0.9)8 and the interincisal angle (Ui–Li)
decreased 2.3 (5.8)8. Furthermore, the overbite and overjet
decreased 1.0 (1.5) mm and 1.7 (1.6) mm, respectively.
Concerning facial height there was an increase in the lower
anterior facial height (0.8  1.5 mm) and the total anterior
facial height (0.9  1.4 mm), resulting in a decrease of the
anterior facial height ratio (0.8  1.9%). No significant changes
were observed in any of the variables regarding the posterior
facial heights.
When adjusted for regression-to-the-mean effects, our
data show significant, mainly dental changes in the craniofa-
cial morphology in the oral-appliance group compared with
the CPAP group following 2 years of treatment (Table 2 and
Fig. 3). A retroclination of the upper incisors (d = 0.6) and a
proclination of the lower incisors (d = 0.7) was found, the
overjet (d = 1.3) and overbite (d = 0.6) had decreased, and the
lower anterior facial height (d = 0.6) as well as the total anterior
facial height (d = 0.5) had increased in the oral-appliance group
compared with the CPAP group. Conversely, the anterior facial
height ratio did not change significantly when comparing the
oral-appliance and CPAP group.
Linear regression analysis revealed that the decrease in
overbite was significantly associated with the mean mandib-
ular protrusion during follow-up (B = 0.029, SE = 0.014,
p < 0.05). The control (CPAP) group did not reveal any
significant changes in the craniofacial morphology after 2
years of treatment.through the posterior nasal spine (pns) and the anterior
nasal spine (ans)), SN (sella-nasion line: the line through
sella and nasion), SN-perp (SN-perpendicular: the line
through Sella (S) perpendicular on line SN), Ui (upper
incisor line: the line through the upper incisor apex and
the upper incisor incisal edge).
[(Fig._3)TD$FIG]
Fig. 3 – Craniofacial changes represented in an overall
tracing, before (thick line) and after (thin line) oral-
appliance therapy.
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To our knowledge, this is the first study in which changes in
craniofacial morphology as a result of long-term oral-appli-
ance therapy are evaluated in a controlled study concerning
patients from the full OSAHS spectrum. The results of this
study indicate that changes in craniofacial morphology should
be anticipated in OSAHS patients using an oral-appliance for 2
years when compared with CPAP therapy. These changes,
however, were predominantly dental in nature. Furthermore,
by using linear regression analysis, an association was
observed between the mean mandibular protrusion during
the follow-up period and the decrease in overbite.
Changes in overbite and overjet, retroclination of the upper
incisors and a proclination of the lower incisors have also been
described in previous studies.8,15,23,24 These changes have
been attributed to a labially directed force to the mandibular
incisors and a palatally directed force to the maxillary incisors
while the appliance is in place and the mandible attempts to
return to a less constrained position. Conversely, Ringqvist
et al.20 did not find significant changes in overbite, overjet, and
inclination of the upper or lower incisors after 2 years of oral-
appliance use. A first explanation for this erratic result could
be the different design of the oral-appliance used in their
study. The frontal parts of both tooth arches were not covered
by acrylate. Therefore, the palatally and labially directed
forces were not applied directly to the upper and lower
incisors, respectively. Another explanation could be the
degree of mandibular protrusion of 50% while wearing the
oral-appliance. Both explanations seem viable but it is unclear
to what extent each of these possibilities contributes to the
observed differences.Protrusive positions of the mandible over 75% of the
patient’s maximum were applied in some patients in the
present study. This could be explained by the fact that patients
with mild, moderate, and severe OSAHS were included. Severe
OSAHS patients may need more pronounced protrusive
positions of the mandible in order to experience sufficient
benefit from the oral-appliance. Ringqvist et al.20 only
included patients with mild-to-moderate disease. As dose
dependency of oral-appliance therapy has previously been
described,34 it is conceivable that the oral-appliance in this
category is already effective in a less protrusive position,
resulting in less severe dental side-effects.
In the oral-appliance group, we found a backward
(decreased Me-hor) and downward (increased Me-ver) rotation
of the mandible, resulting in small but significant increases in
the lower and total anterior facial heights, but not in the
anterior facial height ratio. These findings corroborate the
results from previous studies.19,22,23 It could be hypothesized
that over-eruption of the molars, caused by possible inade-
quacies in the oral-appliance’s fit during follow-up, results in
an increase in anterior facial height. However, in the present
study the quality and fit of the oral-appliances was checked
annually and adjusted if required. Therefore, it seems unlikely
that this mechanism explains the increase in the lower and
total anterior facial heights in our study. The small increase in
anterior facial height is most likely the result of oral-
appliance-induced dental changes. The retroclination of the
upper incisors and the proclination of the lower incisors result
in a downward rotation of the mandible through incisal
guidance, most likely resulting in a small but significant
increase in the total and lower anterior facial height.35
Bondemark21 found an increase in mandibular length after 2
years of oral-appliance use. We did not observe any significant
changes in mandibular length (Arm–Me), ramus length (Arm–
Go) or mandibular body length (Go–Me) in our patients. This
discrepancy could be explained by the differences in mandibu-
lar landmarks used. Bondemark used the linear distance
between condylion (Cd) and pogonion (Pg). We calculated
mandibular length as the linear distance between articulare
midpoint (Arm) and menton (Me). Pogonion could be an
unreliable landmark if rotation of the mandible occurs, because
the most anterior point of the mandibular symphysis will be
displaced. However, menton is an anatomical landmark rather
than a constructed landmark and, therefore, is more reliable
when mandibular rotation is to be expected. Furthermore, it has
been suggested that articulare is more reproducible than
condylion on cephalograms exposed in habitual occlusion.36
We constructed the landmark articulare midpoint (Arm) as we
hypothesized that this point is less susceptible to displacement
when rotation of the mandible occurs.37
It could be hypothesized that the long-term use of CPAP
causes changes in the dental or skeletal morphology as a result
of its tight-fitting (mouth-) nose mask. However, in the present
study we did not find any changes in either dental- or skeletal
variables in the CPAP group. Therefore, in retrospect the CPAP
group appeared to be adequate as a control group.
In this study an adjustable oral-appliance was used. The
regression analysis showed that there appears to be an
association between the decrease in overbite and the extent
of mandibular protrusion. Therefore, it appears to be of
j o u r n a l o f d e n t i s t r y 3 8 ( 2 0 1 0 ) 1 0 1 0 – 1 0 1 8 1017importance to keep the mandibular protrusion associated with
oral-appliance use to a minimum. This finding may become
increasingly important, as with increasing age OSAHS symp-
tomatology may worsen in patients who require a more
extended protrusive mandibular position. It could be hypothe-
sized that the extent of dental side effects might be more
pronounced with adjustable appliances as there is a risk of
advancing the mandible beyond an optimum position. As a
result of including severe OSAHS patients in this study, the
mean mandibular protrusion might be larger in the present
sample when compared with other studies that only studied
patients with mild-moderate OSAHS or snorers without
OSAHS.
Martinez-Gomis et al.38 found a significant reduction in the
number of posterior occlusal contacts after 2 years use of oral-
appliance. This tendency however, reversed during the period
of 2–5 years of treatment. Therefore it seems viable that most
dental changes occur during the first years of treatment with
an oral-appliance but tend to stabilize over time.
Inter- and intraobserver reliability measurements were not
carried out in this study. However, in a recent study,26
interclass correlation coefficients (ICCs) were calculated for
two experienced observers (MD and GP) after digital tracings
using Viewbox 3.1.1.6 software1. Except for one, all ICCs were
considered excellent (range 0.69–0.97).
Notwithstanding the fact that this study was prospective in
design, the randomization and sample size calculation were
performed based on the primary outcome measure for the
randomized controlled trial by Hoekema et al.7. A post-
analysis power calculation, using the change in overjet as
clinical most important outcome variable, yielded a power of
88% (n1 = 31, n2 = 37, a = 0.05).
In conclusion, our results show that the long-term use of an
oral-appliance causes predominantly dental changes in the
craniofacial morphology in OSAHS patients. All effect sizes of
the observed significant changes, expressed as Cohen’s d,
were medium-to-large and should be considered as clinically
important. Nevertheless, a disorder with serious cardiovascu-
lar consequences should be treated as effective as possible.
This supersedes the maintenance of a patients’ baseline
craniofacial morphology. Discontinuation of oral-appliance
therapy because of the development of craniofacial side-
effects should only be considered in patients who are able to
tolerate or accept another effective treatment modality for the
OSAHS. However, in agreement with Almeida et al.,23 we
endorse the importance of collecting clinical data as cast-
models and intra-oral photographs before and during treat-
ment with an oral-appliance. Thus, patients treated with an
oral-appliance need a thorough follow-up by a dentist or
dental-specialist experienced in the field of dental sleep
medicine.
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